B. Dönertaş Et Al. , "Cannabinoids and agmatine as potential therapeutic alternatives for cisplatin-induced peripheral neuropathy," Journal of Experimental Pharmacology , vol.10, pp.19-28, 2018
Dönertaş, B. Et Al. 2018. Cannabinoids and agmatine as potential therapeutic alternatives for cisplatin-induced peripheral neuropathy. Journal of Experimental Pharmacology , vol.10 , 19-28.
Dönertaş, B., Çengelli Ünel, Ç., & Erol, K., (2018). Cannabinoids and agmatine as potential therapeutic alternatives for cisplatin-induced peripheral neuropathy. Journal of Experimental Pharmacology , vol.10, 19-28.
Dönertaş, BAŞAK, ÇİĞDEM ÇENGELLİ ÜNEL, And KEVSER EROL. "Cannabinoids and agmatine as potential therapeutic alternatives for cisplatin-induced peripheral neuropathy," Journal of Experimental Pharmacology , vol.10, 19-28, 2018
Dönertaş, BAŞAK Et Al. "Cannabinoids and agmatine as potential therapeutic alternatives for cisplatin-induced peripheral neuropathy." Journal of Experimental Pharmacology , vol.10, pp.19-28, 2018
Dönertaş, B. Çengelli Ünel, Ç. And Erol, K. (2018) . "Cannabinoids and agmatine as potential therapeutic alternatives for cisplatin-induced peripheral neuropathy." Journal of Experimental Pharmacology , vol.10, pp.19-28.
@article{article, author={BAŞAK AYAZ Et Al. }, title={Cannabinoids and agmatine as potential therapeutic alternatives for cisplatin-induced peripheral neuropathy}, journal={Journal of Experimental Pharmacology}, year=2018, pages={19-28} }